BR9711777A - Processo para produzir formas de dosagem sÄlidas mediante a mistura de pelo menos um aglutinante polimerico - Google Patents

Processo para produzir formas de dosagem sÄlidas mediante a mistura de pelo menos um aglutinante polimerico

Info

Publication number
BR9711777A
BR9711777A BR9711777A BR9711777A BR9711777A BR 9711777 A BR9711777 A BR 9711777A BR 9711777 A BR9711777 A BR 9711777A BR 9711777 A BR9711777 A BR 9711777A BR 9711777 A BR9711777 A BR 9711777A
Authority
BR
Brazil
Prior art keywords
mixing
polymeric binder
producing solid
dosage forms
solid dosage
Prior art date
Application number
BR9711777A
Other languages
English (en)
Portuguese (pt)
Inventor
Jorg Breitenbach
Andreas Kleinke
Stephan Kothrade
Joerg Rosenberg
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19637479A external-priority patent/DE19637479A1/de
Priority claimed from DE19734011A external-priority patent/DE19734011A1/de
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9711777A publication Critical patent/BR9711777A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9711777A 1996-09-13 1997-09-11 Processo para produzir formas de dosagem sÄlidas mediante a mistura de pelo menos um aglutinante polimerico BR9711777A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19637479A DE19637479A1 (de) 1996-09-13 1996-09-13 Verfahren zur Herstellung fester pharmazeutischer Formen
DE19734011A DE19734011A1 (de) 1997-08-06 1997-08-06 Verfahren zur Herstellung fester pharmazeutischer Formen
PCT/EP1997/004984 WO1998010752A2 (de) 1996-09-13 1997-09-11 Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung

Publications (1)

Publication Number Publication Date
BR9711777A true BR9711777A (pt) 1999-08-24

Family

ID=26029370

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711777A BR9711777A (pt) 1996-09-13 1997-09-11 Processo para produzir formas de dosagem sÄlidas mediante a mistura de pelo menos um aglutinante polimerico

Country Status (19)

Country Link
US (1) US6221368B1 (enExample)
EP (1) EP0930875B1 (enExample)
JP (1) JP4975894B2 (enExample)
KR (1) KR20000036066A (enExample)
CN (1) CN1230109A (enExample)
AT (1) ATE239452T1 (enExample)
AU (1) AU720535B2 (enExample)
BR (1) BR9711777A (enExample)
CA (1) CA2265532C (enExample)
CZ (1) CZ82999A3 (enExample)
DE (1) DE59710059D1 (enExample)
DK (1) DK0930875T3 (enExample)
ES (1) ES2199373T3 (enExample)
HR (1) HRP970485A2 (enExample)
IL (1) IL128672A0 (enExample)
SK (1) SK26099A3 (enExample)
TR (1) TR199900563T2 (enExample)
TW (1) TW474824B (enExample)
WO (1) WO1998010752A2 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
DE19857897A1 (de) * 1998-12-15 2000-06-21 Basf Ag Verfahren zur Herstellung wäßriger Polymerdispersionen
US6733789B1 (en) 1999-01-21 2004-05-11 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
US20040185099A1 (en) * 2000-01-20 2004-09-23 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
GB0106469D0 (en) * 2001-03-15 2001-05-02 Syngenta Ltd Solid formulation
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
US20030118652A1 (en) * 2001-11-15 2003-06-26 John Kelly Methods and compositions for use of (S)-bisoprolol
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
EP1624859A4 (en) * 2003-05-06 2010-06-23 Bpsi Holdings Inc METHOD FOR PRODUCING THERMOFORMED COMPOSITIONS WITH ACRYLIC POLYMER BINDERS, PHARMACEUTICAL DOSAGE FORMS, AND METHOD FOR THE PRODUCTION THEREOF
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
BRPI0416535A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo
RU2331410C2 (ru) * 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
BRPI0417338A (pt) * 2003-12-04 2007-04-17 Pfizer Prod Inc formas de dosagem de azitromicina multiparticulada por processos a base de lìquido
JP2007513147A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053651A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US7799744B2 (en) * 2005-03-09 2010-09-21 Halliburton Energy Services, Inc. Polymer coated particulates
RU2423997C9 (ru) 2005-07-05 2011-11-20 Эббетт ГмбХ унд Ко. КГ Композиция и лекарственная форма, содержащие твердую или полутвердую матрицу
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
KR20090042860A (ko) * 2006-08-23 2009-04-30 바이엘 크롭사이언스 아게 농약 활성제의 방출 조절용 제제
US8399007B2 (en) * 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms
US20160113906A1 (en) 2014-09-19 2016-04-28 Board Of Regents, The University Of Texas System Methods of preparing extrudates
CN108421497A (zh) * 2018-04-03 2018-08-21 杨高品 药物连续化制粒的生产工艺和设备
KR102757752B1 (ko) 2024-01-31 2025-01-21 (주) 제이아리 강성재질 성형틀 기반의 고형 제형 흡습제 제조 장비
KR20250119038A (ko) 2024-01-31 2025-08-07 주식회사 이엔케이글로벌 신축성재질 성형틀 기반의 고흡수성 고형 제형 흡습제 제조 장비
KR102857226B1 (ko) 2024-02-01 2025-09-09 (주) 제이아리 고흡수성 고형 제형 흡습제 제조 장비

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1388786A (en) 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
DE3208791A1 (de) 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
DE3421860C2 (de) * 1984-06-13 1994-09-15 Roehm Gmbh Verfahren zum Überziehen von Arzneiformen
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
JPS63222112A (ja) * 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性顆粒
JPS63222121A (ja) * 1987-03-10 1988-09-16 Nippon Soda Co Ltd 徐放性ゲル製剤
DE3812567A1 (de) 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
DE3830353A1 (de) 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
GB9025372D0 (en) * 1990-11-22 1991-01-09 Nat Res Dev Pharmaceutical dosage forms
NL9100691A (nl) * 1991-04-19 1992-11-16 Dmv Campina Bv Tabletteerhulpstof.
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
DE4141268A1 (de) 1991-12-14 1993-06-17 Merck Patent Gmbh Pharmazeutische zubereitung
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
JPH06218028A (ja) 1992-10-02 1994-08-09 Eisai Co Ltd 湿製錠の成型方法とその装置及び湿製錠
EP0729748B1 (en) * 1993-11-18 2003-02-26 Nippon Shinyaku Company, Limited Process for producing stable medicinal composition
PT739198E (pt) * 1994-01-20 2004-02-27 Agres Ltd Dispositivo para administracao de substancias beneficas a ruminantes
AU1806895A (en) * 1994-02-23 1995-09-11 Bm Research A/S Controlled release composition

Also Published As

Publication number Publication date
TR199900563T2 (xx) 1999-07-21
EP0930875A2 (de) 1999-07-28
CA2265532A1 (en) 1998-03-19
SK26099A3 (en) 2000-03-13
DE59710059D1 (de) 2003-06-12
JP2001500130A (ja) 2001-01-09
US6221368B1 (en) 2001-04-24
ES2199373T3 (es) 2004-02-16
IL128672A0 (en) 2000-01-31
CZ82999A3 (cs) 1999-06-16
WO1998010752A3 (de) 1998-06-18
EP0930875B1 (de) 2003-05-07
AU4384697A (en) 1998-04-02
TW474824B (en) 2002-02-01
CN1230109A (zh) 1999-09-29
WO1998010752A2 (de) 1998-03-19
JP4975894B2 (ja) 2012-07-11
DK0930875T3 (da) 2003-09-01
HRP970485A2 (en) 1998-08-31
ATE239452T1 (de) 2003-05-15
AU720535B2 (en) 2000-06-01
CA2265532C (en) 2006-04-04
KR20000036066A (ko) 2000-06-26

Similar Documents

Publication Publication Date Title
DK0930875T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske former ved ekstrudering
PT1035841E (pt) Processo para o fabrico de formas de dosagem solidas
BR8303344A (pt) Composicao de cimento,processo para produzir um cimento endurecido e composicao de aditivo para uso no processo
NO884948L (no) Dobbeltkammeret blande- og tildelingsampulle.
BR8504463A (pt) Resina quimicamente endurecivel,processo para sua preparacao,misturas de compostos e misturas endurecidas de compostos
BR0011999A (pt) Formas de dosagem farmacêutica para liberação controlada produzindo pelo menos um pulso cronometrado
DE59908773D1 (de) Teilbare feste dosierungsformen und verfahren zu ihrer herstellung
PY950041A (es) Compuesto de 1- fenil 3-dimetilamino- propano a procedimientos para su preparacion y a la aplicacion de estas sustancias en farmacologia
BR8803874A (pt) Composicao de aditivo,composicao de mistura,e,composicao de combustivel
ES2158141T3 (es) Proceso para fabricacion de chocolate con reducido contenido de grasa.
RU94026253A (ru) Композиция из эластомерных полипропиленов и неолефиновых термопластов, способ их получения
HK1003825A1 (en) Polymer beads containing antibiotics for use in orthopaedic surgery
NO2009009I2 (no) Tocilizumab
BR9304846A (pt) Processo para a preparação de uma composição de tinta, composição de tinta preparada pelo mesmo e processo de impressão com tinta.
BR9103934A (pt) Misturas de substancias contendo fenotiazina,composicao,processo para a preparacao de uma mistura de substancias e emprego
SE8201202L (sv) Anti-inflammatoriskt analgetiskt kataplasma
ES2163147T3 (es) Perfeccionamientos de agentes antimicrobianos de accion prolongada o relativos a los mismos.
ES2002035A6 (es) Un metodo para formar una composicion de pavimentacion de cemento asfaltico
BR9402686A (pt) Processo para a preparação de poliéteres, poliéteres, composição, processo para estabilizar polímeros orgânicos e aplicação.
ATE221777T1 (de) Pharmazeutische zusammensetzungen, die paracetamol und l-cystein oder einen vorlaeufer davon enthalten
AR002656A1 (es) Un procedimiento para la produccion de una composicion o componente detergente que posee una densidad de volumen inferior a 700 g/l y composiciono componente detergente obtenido con el mismo.
FI812131A7 (fi) Farmaseuttinen seos, jolla on antiflogistinen, antipyreettinen ja analgeesinen vaikutus.
JPS5228705A (en) Concrete press feeding pump
ES2067622T3 (es) Proceso para preparar una composicion farmaceutica.
ES2067829T3 (es) Mezcla para enlucidos.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]